Fresenius Medical Care Release: North AmericaPartnership Healthplan Of California Cooperates With Optimal Renal Care; Launch Of New Program To Treat Chronic Kidney Disease Patients

LEXINGTON, Mass.--(BUSINESS WIRE)--April 19, 2005--Fresenius Medical Care North America, a subsidiary of Fresenius Medical Care AG (Frankfurt Stock Exchange: FME, FME3) (NYSE: FMS, FMS-p), the world’s largest provider of Dialysis Products and Services, today announced that the Partnership HealthPlan of California (PHC), has launched a special program geared to care for its patients with chronic kidney disease. PHC, which estimates that it has 40-50 members who are eligible for the program, is contracting with Optimal Renal Care, one of the largest providers of kidney disease management services in the country. The overall goal of the program is to improve the outcomes and quality of life for the members who typically face three lengthy dialysis treatments a week. “PHC is very pleased to enter this partnership with Optimal Renal Care. Optimal Renal Care is recognized as a leader in the field of disease management in this area and they have shown excellent results in improving clinical outcomes for patients on dialysis in other areas. Together, we expect to improve the health and quality of life for our members afflicted with chronic kidney disease,” according to Dr. Chris Cammisa, medical director at PHC.